Industry: Machinery & Equipment
Published Date: 2026-08-15
Pages: 164 Pages
Report ld: 5831564
Request Sample
Customized Report
KEY FINDINGS
In 2025, global Automated ELISA Analyzer production reached approximately 4,836 Units.The average price is approximately $80,000
Europe remains the deepest specialized manufacturing cluster, while China has developed a broad regional Automated ELISA Analyzer OEM base
Mainstream Chinese systems generally occupy lower price bands, while higher-end European and North American platforms command substantially higher ASPs
Open microplate systems remain the principal commercial architecture, while dedicated monotest platforms retain importance in specialized immunodiagnostics
Replacement demand and laboratory automation upgrades are becoming more important than large-scale greenfield installation
Automated ELISA Analyzer Market Size(US$)

CAGR 2026-2032
3.7%
Market Size,2032
USD 496
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Automated ELISA Analyzer market was valued at US$ 387 million in 2025 and is anticipated to reach US$ 496 million by 2032, at a CAGR of 3.7% from 2026 to 2032.
Automated ELISA Analyzer refers to an integrated laboratory instrument designed to automate the principal operating steps of enzyme-linked immunosorbent assays, including sample identification, sample and reagent dispensing, dilution, incubation, shaking, microplate or microwell-strip washing, enzymatic color development, absorbance measurement, result calculation and laboratory information-system connectivity. The market primarily covers dedicated ELISA automation systems based on 96-well microplates, removable microwell strips and selected monotest formats, ranging from compact benchtop processors to multi-plate, medium- and high-throughput workstations. Systems may operate as open platforms capable of processing assays from multiple reagent suppliers or as dedicated platforms optimized around specific assay menus and consumable formats. Automated ELISA Analyzer is used principally in infectious-disease serology, autoimmune diagnostics, blood screening and other clinical immunoassays, while additional demand comes from pharmaceutical and biotechnology bioanalysis, vaccine research, academic laboratories, veterinary diagnostics and selected food-testing applications. The core value of the equipment lies in reducing manual intervention, improving workflow consistency and traceability, increasing processing capacity and standardizing multi-step ELISA procedures.
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers
Demand for Automated ELISA Analyzer is supported by laboratories seeking to reduce manual pipetting, improve inter-run consistency and increase traceability in multi-step ELISA workflows. Clinical serology, autoimmune testing and blood-screening laboratories continue to use established ELISA methods where assay availability, validated protocols and open-system economics remain important. Medium- and high-throughput laboratories also benefit from automated sample handling and multi-plate processing; for example, EUROIMMUN’s Analyzer I is designed for fully automated processing of up to seven microplates and 180 patient samples per run, demonstrating the operational value of automation in routine ELISA environments.
Restraints
The principal restraint is substitution by alternative immunoassay technologies, particularly random-access chemiluminescence systems in routine clinical diagnostics and newer high-sensitivity technologies in advanced biomarker research. Traditional ELISA also remains inherently batch-oriented in many workflows, which can reduce its attractiveness for laboratories requiring rapid random-access testing. Mature installed bases, long replacement cycles and customer reluctance to replace validated workflows further limit rapid equipment expansion. In addition, smaller laboratories may continue to use combinations of manual pipetting, plate washers and readers when test volumes do not justify investment in a dedicated automated platform.
Opportunities
The strongest opportunities are concentrated in replacement of aging installed systems, conversion of manual and semi-automated laboratories to walk-away processing, expansion of open-system platforms in cost-sensitive markets and automation of specialized ELISA applications that remain difficult to migrate to standardized high-throughput immunoassay systems. China and other emerging laboratory markets offer additional opportunities for locally manufactured systems combining lower acquisition costs with domestic service capabilities. Pharmaceutical and biotechnology laboratories also represent an attractive niche where assay reproducibility, audit trails, standardized sample preparation and regulatory-oriented data control can justify higher levels of ELISA automation.
Challenges
Manufacturers must balance automation depth, assay flexibility, reliability and equipment cost while supporting a highly fragmented global reagent environment. Open systems need broad protocol compatibility and stable liquid-handling performance, whereas dedicated platforms must maintain sufficient assay menus and consumable availability to support customer retention. The industry also faces increasingly demanding software, cybersecurity, connectivity and compliance requirements. At the same time, smaller regional manufacturers must establish international quality systems, regulatory registrations and after-sales networks before they can compete effectively with established global suppliers, making commercial expansion more difficult than instrument development alone.
INDUSTRY CHAIN ANALYSIS
The upstream chain of the Automated ELISA Analyzer industry consists primarily of precision liquid-handling components, pumps and valves, optical absorbance modules, incubation and temperature-control components, washing modules, robotic motion systems, barcode readers, embedded electronics, computing hardware, molded plastic components and software. Equipment reliability depends heavily on dispensing accuracy, carryover control, optical stability and coordinated control of multiple mechanical and fluidic modules. For manufacturers, the most technically and economically important activities are system architecture, liquid-handling engineering, assay-workflow integration, software development, verification and validation, regulatory compliance, final assembly and quality control. STRATEC, for example, describes its business as the design and manufacture of fully automated analyzer systems, software and smart consumables for diagnostic and life-science OEM partners, illustrating the role of specialist instrumentation developers within the value chain.
Downstream value is created through instrument sales, installation, application configuration, service support and, for assay-integrated suppliers, recurring reagent and consumable demand. Clinical laboratories and blood-screening facilities place greater emphasis on reliability, throughput and service availability, while pharmaceutical and research users value protocol flexibility, data integrity and method reproducibility. The economics of the market therefore differ between open hardware-focused suppliers and integrated instrument-reagent vendors: the former rely more heavily on equipment, service and OEM relationships, whereas the latter can generate longer-term customer value through proprietary assay menus and consumables.
SEGMENT INSIGHTS
By automation architecture, integrated microplate batch analyzers remain the principal commercial product form because the 96-well format is deeply established across clinical and research ELISA workflows. Within this segment, low- and medium-throughput instruments address decentralized and routine laboratories, while multi-plate platforms target centralized laboratories and higher-volume testing. EUROIMMUN’s current portfolio illustrates this tiered approach, with the Analyzer I-2P designed for up to three microplates and the Analyzer I supporting up to seven plates. Microstrip-based systems remain relevant where laboratories require flexible batch sizes, while dedicated monotest architectures are more concentrated in specialty immunodiagnostic applications.
System openness is another important commercial segmentation dimension. Open platforms provide laboratories with flexibility to run assays from multiple reagent suppliers and therefore compete on protocol programming, liquid-handling precision and instrument reliability. STRATEC’s GEMINI, for example, is positioned as an open ELISA solution and supports continuous loading, reflecting the continuing demand for flexible laboratory workflows. Dedicated systems compete differently, using closer integration between analyzer, assay menu and consumable format to improve ease of use and customer retention. This distinction is increasingly important for competitive analysis because the recurring-revenue potential and switching costs of the two models differ materially.
DOWNSTREAM MARKET OPPORTUNITIES
Clinical laboratories remain the central downstream market for Automated ELISA Analyzer, particularly in infectious-disease serology, autoimmune diagnostics and blood-related testing where established ELISA protocols continue to provide broad assay availability and favorable economics. The most attractive incremental demand is likely to come from laboratories upgrading manual or semi-automated workflows, facilities replacing aging installed analyzers and users requiring stronger traceability and standardized processing. Pharmaceutical and biotechnology applications offer a smaller but strategically attractive opportunity, particularly for bioanalytical workflows requiring reproducible sample preparation, assay automation, electronic records and regulatory-oriented data management. Veterinary, food and selected environmental laboratories represent additional long-tail demand for open systems able to process heterogeneous ELISA kits.
REGIONAL INSIGHTS

Fastest-Growing Region: Asia Pacific
Europe has the deepest specialized supplier base, with a concentration of long-established ELISA automation and diagnostic-instrument companies in Germany, Italy, Switzerland and neighboring markets. The region benefits from accumulated expertise in IVD engineering, specialty immunodiagnostics and OEM analyzer development. North America has fewer dedicated manufacturers but includes globally established specialists with substantial international distribution and installed bases. DYNEX states that it operates through partners in more than 120 countries, illustrating the global reach achievable by specialized North American ELISA automation suppliers. These mature markets are increasingly driven by replacement, software upgrades and workflow modernization rather than first-time automation.
BY TYPE,2021-2032(US $ MILLION)
Integrated Microplate Batch Analyzer
Microstrip-based ELISA Processor
Dedicated Monotest ELISA System
Others
BY APPLICATION,2021-2032(US $ MILLION)
Infectious Disease Serology
Autoimmune Diagnostics
Blood Screening and Transfusion
Others
China represents the most important regional manufacturing expansion story within the existing supplier pool. The confirmed database contains multiple domestic equipment manufacturers serving hospitals, blood-screening laboratories and export markets, creating a broader price spectrum and increasing competition in entry- and mid-range systems. India has meaningful manufacturing participation through the Transasia-Erba ecosystem, whereas Japan, South Korea, Taiwan, Southeast Asia and the Middle East have comparatively fewer verified dedicated Automated ELISA Analyzer OEMs under the narrow definition. These regions nevertheless remain relevant demand markets, particularly for imported open platforms and cost-effective systems distributed through local diagnostic channels.
COMPETITIVE LANDSCAPE ANALYSIS
The Automated ELISA Analyzer market has a fragmented, multi-tier competitive structure rather than the concentrated pattern seen in some large-scale chemiluminescence immunoassay categories. The core formal list contains 21 verified manufacturers or corporate groups, supplemented by regional suppliers and several companies retained in the extended pool because of OEM, historical-platform or manufacturing-identity considerations. Global specialists such as DYNEX compete primarily through established installed bases, open-assay flexibility and dedicated ELISA automation expertise, while assay-focused groups such as EUROIMMUN and specialty immunodiagnostic suppliers can combine instrumentation with assay portfolios. European instrumentation specialists such as STRATEC and Tecan also demonstrate the importance of OEM engineering and contract manufacturing in the industry. STRATEC reported strong growth in immunoassay systems in 2025 and continues to offer open ELISA platforms including GEMINI and the newer FNX nova, indicating that established European suppliers continue to invest in this application area. Chinese manufacturers compete more strongly on acquisition cost, local service, customization and export-oriented value propositions. Future competition is expected to center increasingly on software, connectivity, workflow flexibility, assay compatibility, data integrity and lifecycle service, while manufacturers unable to differentiate beyond basic mechanical automation will face greater pricing pressure and substitution risk.
REPORT SCOPE
This report delivers a comprehensive overview of the global Automated ELISA Analyzer market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Automated ELISA Analyzer. The Automated ELISA Analyzer market size, estimates, and forecasts are provided in terms of output/shipments (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Automated ELISA Analyzer market comprehensively. Regional market sizes by Type, by Application, by System Openness, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Automated ELISA Analyzer manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by System Openness, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Automated ELISA Analyzer manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Automated ELISA Analyzer production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Automated ELISA Analyzer consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Automated ELISA Analyzer Market Overview
1.1 Product Definition
1.2 Automated ELISA Analyzer by Type
1.2.1 Global Automated ELISA Analyzer Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Integrated Microplate Batch Analyzer
1.2.3 Microstrip-based ELISA Processor
1.2.4 Dedicated Monotest ELISA System
1.2.5 Others
1.3 Automated ELISA Analyzer by System Openness
1.3.1 Global Automated ELISA Analyzer Market Value Growth Rate Analysis by System Openness: 2025 vs 2032
1.3.2 Open System
1.3.3 Closed System
1.3.4 Hybrid System
1.3.5 Others
1.4 Automated ELISA Analyzer by System Throughput
1.4.1 Global Automated ELISA Analyzer Market Value Growth Rate Analysis by System Throughput: 2025 vs 2032
1.4.2 Low-throughput: 1–2 Plates
1.4.3 Medium-throughput: 3–4 Plates
1.4.4 High-throughput: ≥5 Plates
1.4.5 Others
1.5 Automated ELISA Analyzer by Application
1.5.1 Global Automated ELISA Analyzer Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.5.2 Infectious Disease Serology
1.5.3 Autoimmune Diagnostics
1.5.4 Blood Screening and Transfusion
1.5.5 Others
1.6 Global Market Growth Prospects
1.6.1 Global Automated ELISA Analyzer Production Value Estimates and Forecasts (2021–2032)
1.6.2 Global Automated ELISA Analyzer Production Capacity Estimates and Forecasts (2021–2032)
1.6.3 Global Automated ELISA Analyzer Production Estimates and Forecasts (2021–2032)
1.6.4 Global Automated ELISA Analyzer Market Average Price Estimates and Forecasts (2021–2032)
1.7 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Automated ELISA Analyzer Production Market Share by Manufacturers (2021–2026)
2.2 Global Automated ELISA Analyzer Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Automated ELISA Analyzer, Industry Ranking, 2024 vs 2025
2.4 Global Automated ELISA Analyzer Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Automated ELISA Analyzer Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Automated ELISA Analyzer, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Automated ELISA Analyzer, Product Offerings and Applications
2.8 Global Key Manufacturers of Automated ELISA Analyzer, Date of Entry into the Industry
2.9 Automated ELISA Analyzer Market Competitive Situation and Trends
2.9.1 Automated ELISA Analyzer Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Automated ELISA Analyzer Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Automated ELISA Analyzer Production by Region
3.1 Global Automated ELISA Analyzer Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Automated ELISA Analyzer Production Value by Region (2021–2032)
3.2.1 Global Automated ELISA Analyzer Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Automated ELISA Analyzer by Region (2027–2032)
3.3 Global Automated ELISA Analyzer Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Automated ELISA Analyzer Production Volume by Region (2021–2032)
3.4.1 Global Automated ELISA Analyzer Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Automated ELISA Analyzer by Region (2027–2032)
3.5 Global Automated ELISA Analyzer Market Price Analysis by Region (2021–2032)
3.6 Global Automated ELISA Analyzer Production, Value, and Year-over-Year Growth
3.6.1 North America Automated ELISA Analyzer Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Automated ELISA Analyzer Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Automated ELISA Analyzer Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Automated ELISA Analyzer Production Value Estimates and Forecasts (2021–2032)
4 Automated ELISA Analyzer Consumption by Region
4.1 Global Automated ELISA Analyzer Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Automated ELISA Analyzer Consumption by Region (2021–2032)
4.2.1 Global Automated ELISA Analyzer Consumption by Region (2021–2026)
4.2.2 Global Automated ELISA Analyzer Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Automated ELISA Analyzer Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Automated ELISA Analyzer Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Automated ELISA Analyzer Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Automated ELISA Analyzer Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Automated ELISA Analyzer Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Automated ELISA Analyzer Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Automated ELISA Analyzer Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Automated ELISA Analyzer Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Automated ELISA Analyzer Production by Type (2021–2032)
5.1.1 Global Automated ELISA Analyzer Production by Type (2021–2026)
5.1.2 Global Automated ELISA Analyzer Production by Type (2027–2032)
5.1.3 Global Automated ELISA Analyzer Production Market Share by Type (2021–2032)
5.2 Global Automated ELISA Analyzer Production Value by Type (2021–2032)
5.2.1 Global Automated ELISA Analyzer Production Value by Type (2021–2026)
5.2.2 Global Automated ELISA Analyzer Production Value by Type (2027–2032)
5.2.3 Global Automated ELISA Analyzer Production Value Market Share by Type (2021–2032)
5.3 Global Automated ELISA Analyzer Price by Type (2021–2032)
6 Segment by Application
6.1 Global Automated ELISA Analyzer Production by Application (2021–2032)
6.1.1 Global Automated ELISA Analyzer Production by Application (2021–2026)
6.1.2 Global Automated ELISA Analyzer Production by Application (2027–2032)
6.1.3 Global Automated ELISA Analyzer Production Market Share by Application (2021–2032)
6.2 Global Automated ELISA Analyzer Production Value by Application (2021–2032)
6.2.1 Global Automated ELISA Analyzer Production Value by Application (2021–2026)
6.2.2 Global Automated ELISA Analyzer Production Value by Application (2027–2032)
6.2.3 Global Automated ELISA Analyzer Production Value Market Share by Application (2021–2032)
6.3 Global Automated ELISA Analyzer Price by Application (2021–2032)
7 Key Companies Profiled
7.1 DYNEX Technologies
7.1.1 DYNEX Technologies Automated ELISA Analyzer Company Information
7.1.2 DYNEX Technologies Automated ELISA Analyzer Product Portfolio
7.1.3 DYNEX Technologies Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 DYNEX Technologies Main Business and Markets Served
7.1.5 DYNEX Technologies Recent Developments/Updates
7.2 Revvity
7.2.1 Revvity Automated ELISA Analyzer Company Information
7.2.2 Revvity Automated ELISA Analyzer Product Portfolio
7.2.3 Revvity Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Revvity Main Business and Markets Served
7.2.5 Revvity Recent Developments/Updates
7.3 Gold Standard Diagnostics
7.3.1 Gold Standard Diagnostics Automated ELISA Analyzer Company Information
7.3.2 Gold Standard Diagnostics Automated ELISA Analyzer Product Portfolio
7.3.3 Gold Standard Diagnostics Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Gold Standard Diagnostics Main Business and Markets Served
7.3.5 Gold Standard Diagnostics Recent Developments/Updates
7.4 Tecan
7.4.1 Tecan Automated ELISA Analyzer Company Information
7.4.2 Tecan Automated ELISA Analyzer Product Portfolio
7.4.3 Tecan Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Tecan Main Business and Markets Served
7.4.5 Tecan Recent Developments/Updates
7.5 STRATEC
7.5.1 STRATEC Automated ELISA Analyzer Company Information
7.5.2 STRATEC Automated ELISA Analyzer Product Portfolio
7.5.3 STRATEC Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 STRATEC Main Business and Markets Served
7.5.5 STRATEC Recent Developments/Updates
7.6 Transasia/Erba
7.6.1 Transasia/Erba Automated ELISA Analyzer Company Information
7.6.2 Transasia/Erba Automated ELISA Analyzer Product Portfolio
7.6.3 Transasia/Erba Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Transasia/Erba Main Business and Markets Served
7.6.5 Transasia/Erba Recent Developments/Updates
7.7 Aikang MedTech
7.7.1 Aikang MedTech Automated ELISA Analyzer Company Information
7.7.2 Aikang MedTech Automated ELISA Analyzer Product Portfolio
7.7.3 Aikang MedTech Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Aikang MedTech Main Business and Markets Served
7.7.5 Aikang MedTech Recent Developments/Updates
7.8 HUMAN
7.8.1 HUMAN Automated ELISA Analyzer Company Information
7.8.2 HUMAN Automated ELISA Analyzer Product Portfolio
7.8.3 HUMAN Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 HUMAN Main Business and Markets Served
7.8.5 HUMAN Recent Developments/Updates
7.9 Adaltis
7.9.1 Adaltis Automated ELISA Analyzer Company Information
7.9.2 Adaltis Automated ELISA Analyzer Product Portfolio
7.9.3 Adaltis Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Adaltis Main Business and Markets Served
7.9.5 Adaltis Recent Developments/Updates
7.10 Jiaxing CRED
7.10.1 Jiaxing CRED Automated ELISA Analyzer Company Information
7.10.2 Jiaxing CRED Automated ELISA Analyzer Product Portfolio
7.10.3 Jiaxing CRED Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Jiaxing CRED Main Business and Markets Served
7.10.5 Jiaxing CRED Recent Developments/Updates
7.11 BIOBASE
7.11.1 BIOBASE Automated ELISA Analyzer Company Information
7.11.2 BIOBASE Automated ELISA Analyzer Product Portfolio
7.11.3 BIOBASE Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 BIOBASE Main Business and Markets Served
7.11.5 BIOBASE Recent Developments/Updates
7.12 DIESSE
7.12.1 DIESSE Automated ELISA Analyzer Company Information
7.12.2 DIESSE Automated ELISA Analyzer Product Portfolio
7.12.3 DIESSE Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 DIESSE Main Business and Markets Served
7.12.5 DIESSE Recent Developments/Updates
7.13 Sebia/ORGENTEC
7.13.1 Sebia/ORGENTEC Automated ELISA Analyzer Company Information
7.13.2 Sebia/ORGENTEC Automated ELISA Analyzer Product Portfolio
7.13.3 Sebia/ORGENTEC Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Sebia/ORGENTEC Main Business and Markets Served
7.13.5 Sebia/ORGENTEC Recent Developments/Updates
7.14 BERTHOLD
7.14.1 BERTHOLD Automated ELISA Analyzer Company Information
7.14.2 BERTHOLD Automated ELISA Analyzer Product Portfolio
7.14.3 BERTHOLD Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 BERTHOLD Main Business and Markets Served
7.14.5 BERTHOLD Recent Developments/Updates
7.15 Addcare
7.15.1 Addcare Automated ELISA Analyzer Company Information
7.15.2 Addcare Automated ELISA Analyzer Product Portfolio
7.15.3 Addcare Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 Addcare Main Business and Markets Served
7.15.5 Addcare Recent Developments/Updates
7.16 Maide Technology
7.16.1 Maide Technology Automated ELISA Analyzer Company Information
7.16.2 Maide Technology Automated ELISA Analyzer Product Portfolio
7.16.3 Maide Technology Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.16.4 Maide Technology Main Business and Markets Served
7.16.5 Maide Technology Recent Developments/Updates
7.17 Teknolabo
7.17.1 Teknolabo Automated ELISA Analyzer Company Information
7.17.2 Teknolabo Automated ELISA Analyzer Product Portfolio
7.17.3 Teknolabo Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.17.4 Teknolabo Main Business and Markets Served
7.17.5 Teknolabo Recent Developments/Updates
7.18 A.S.T.
7.18.1 A.S.T. Automated ELISA Analyzer Company Information
7.18.2 A.S.T. Automated ELISA Analyzer Product Portfolio
7.18.3 A.S.T. Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.18.4 A.S.T. Main Business and Markets Served
7.18.5 A.S.T. Recent Developments/Updates
7.19 Laibo Technology
7.19.1 Laibo Technology Automated ELISA Analyzer Company Information
7.19.2 Laibo Technology Automated ELISA Analyzer Product Portfolio
7.19.3 Laibo Technology Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.19.4 Laibo Technology Main Business and Markets Served
7.19.5 Laibo Technology Recent Developments/Updates
7.20 IMADEK
7.20.1 IMADEK Automated ELISA Analyzer Company Information
7.20.2 IMADEK Automated ELISA Analyzer Product Portfolio
7.20.3 IMADEK Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.20.4 IMADEK Main Business and Markets Served
7.20.5 IMADEK Recent Developments/Updates
7.21 TAILORED Medical
7.21.1 TAILORED Medical Automated ELISA Analyzer Company Information
7.21.2 TAILORED Medical Automated ELISA Analyzer Product Portfolio
7.21.3 TAILORED Medical Automated ELISA Analyzer Production, Value, Price, and Gross Margin (2021–2026)
7.21.4 TAILORED Medical Main Business and Markets Served
7.21.5 TAILORED Medical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Automated ELISA Analyzer Industry Chain Analysis
8.2 Automated ELISA Analyzer Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Automated ELISA Analyzer Production Modes and Processes
8.4 Automated ELISA Analyzer Sales and Marketing
8.4.1 Automated ELISA Analyzer Sales Channels
8.4.2 Automated ELISA Analyzer Distributors
8.5 Automated ELISA Analyzer Customer Analysis
9 Automated ELISA Analyzer Market Dynamics
9.1 Automated ELISA Analyzer Industry Trends
9.2 Automated ELISA Analyzer Market Drivers
9.3 Automated ELISA Analyzer Market Challenges
9.4 Automated ELISA Analyzer Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Automated ELISA Analyzer market is projected to grow from US$ 387 million in 2025 to US$ 496 million by 2032, at a CAGR of 3.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-15
Pages: 191
USD 4900.00
(Single User License)
The global Automated ELISA Analyzer market size was US$ 387 million in 2025 and is forecast to reach a readjusted size of US$ 496 million by 2032 with a CAGR of 3.7% during the forecast period 2026-2032.
Published Date: 2026-08-15
Pages: 163
USD 4250.00
(Single User License)
The global market for Automated ELISA Analyzer was estimated to be worth US$ 387 million in 2025 and is projected to reach US$ 496 million, growing at a CAGR of 3.7% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 161
USD 3950.00
(Single User License)
The global Automated ELISA Analyzer market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 140
USD 4900.00
(Single User License)
The global Automated ELISA Analyzer market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-13
Pages: 77
USD 4250.00
(Single User License)
The global market for Automated ELISA Analyzer was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-13
Pages: 99
USD 3950.00
(Single User License)
The global market for Automated ELISA Analyzer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-13
Pages: 86
USD 2900.00
(Single User License)
The global Automated ELISA Analyzer market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-14
Pages: 107
USD 4900.00
(Single User License)
The global Automated ELISA Analyzer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-19
Pages: 96
USD 2900.00
(Single User License)
The global Automated ELISA Analyzer market is projected to grow from US$ 387 million in 2025 to US$ 496 million by 2032, at a CAGR of 3.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-15
Pages: 191
The global Automated ELISA Analyzer market size was US$ 387 million in 2025 and is forecast to reach a readjusted size of US$ 496 million by 2032 with a CAGR of 3.7% during the forecast period 2026-2032.
Published: 2026-08-15
Pages: 163
The global market for Automated ELISA Analyzer was estimated to be worth US$ 387 million in 2025 and is projected to reach US$ 496 million, growing at a CAGR of 3.7% from 2026 to 2032.
Published: 2026-08-15
Pages: 161
The global Automated ELISA Analyzer market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 140
The global Automated ELISA Analyzer market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-13
Pages: 77
The global market for Automated ELISA Analyzer was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-13
Pages: 99
The global market for Automated ELISA Analyzer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-13
Pages: 86
The global Automated ELISA Analyzer market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-14
Pages: 107
The global Automated ELISA Analyzer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-19
Pages: 96
REPORT COVERAGE
DESCRIPTION
KEY FINDINGS
OVERVIEW
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
INDUSTRY CHAIN ANALYSIS
SEGMENT INSIGHTS
DOWNSTREAM MARKET OPPORTUNITIES
REGIONAL INSIGHTS
COMPETITIVE LANDSCAPE ANALYSIS
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now